Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
G
225220
vs
K
KOSPI 200
Over the past 12 months, Genolution Inc has underperformed KOSPI 200, delivering a return of -35% compared to KOSPI 200's +125% growth.
Stocks Performance
225220 vs KOSPI 200
Performance Gap
225220 vs KOSPI 200
Performance By Year
225220 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Genolution Inc
Glance View
Genolution Inc. is a South Korean life-science company that makes tools for genetic research and molecular testing. Its business centers on products such as laboratory reagents, diagnostic kits, and related research materials used to analyze DNA and RNA in samples from people, animals, or cells. It sells these products to hospitals, laboratories, research institutes, and other biotech customers that need reliable testing and sample analysis. The company makes money by selling these consumable products and by supplying related testing and research services. Because many of its products are used repeatedly in labs, Genolution’s revenue model depends on ongoing demand for tests, experiments, and diagnostic work rather than one-time equipment sales alone. That gives it a steady role in the lab supply chain, where it sits between scientific research and practical medical testing. What makes Genolution’s business different is that it works in a specialized niche where accuracy and consistency matter more than broad branding. Customers buy its products because they help detect and measure genetic material, which is essential for disease testing, research, and development work. In simple terms, Genolution sells the scientific tools that let other companies and labs read genetic information and turn it into usable results.